The global market for Over-The-Counter Medicines for Sore Throat was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Over-The-Counter Medicines for Sore Throat, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Over-The-Counter Medicines for Sore Throat by region & country, by Type, and by Application.
The Over-The-Counter Medicines for Sore Throat market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Over-The-Counter Medicines for Sore Throat.
麻豆原创 Segmentation
By Company
Blackmores Ltd.
Dr. Willmar Schwabe India Pvt. Ltd.
Ernest Jackson & Co. Ltd
GlaxoSmithKline Plc
iNova Pharmaceuticals
Island Abbey Foods Ltd.
Johnson and Johnson
Pfizer Inc.
Prestige Consumer Healthcare Inc.
Reckitt Benckiser Group PLC
Ricola Ltd.
Sanofi SA
The Procter and Gamble Co.
Belmora LLC
DISCH AG
Bliss GVS Pharma Ltd.
Boyd Pharmaceuticals
Cipla Health Ltd.
Lozy's Pharmaceuticals
Thornton and Ross Ltd.
STADA Arzneimittel AG
Segment by Type:
Lozenges
Syrups
Throat Sprays
Painkillers
Others
Segment by Application
Online Pharmacy
Offline Pharmacy
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Over-The-Counter Medicines for Sore Throat manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Over-The-Counter Medicines for Sore Throat in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Over-The-Counter Medicines for Sore Throat in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 麻豆原创 Overview
1.1 Over-The-Counter Medicines for Sore Throat Product Introduction
1.2 Global Over-The-Counter Medicines for Sore Throat 麻豆原创 Size Forecast
1.3 Over-The-Counter Medicines for Sore Throat 麻豆原创 Trends & Drivers
1.3.1 Over-The-Counter Medicines for Sore Throat Industry Trends
1.3.2 Over-The-Counter Medicines for Sore Throat 麻豆原创 Drivers & Opportunity
1.3.3 Over-The-Counter Medicines for Sore Throat 麻豆原创 Challenges
1.3.4 Over-The-Counter Medicines for Sore Throat 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Over-The-Counter Medicines for Sore Throat Players Revenue Ranking (2023)
2.2 Global Over-The-Counter Medicines for Sore Throat Revenue by Company (2019-2024)
2.3 Key Companies Over-The-Counter Medicines for Sore Throat Manufacturing Base Distribution and Headquarters
2.4 Key Companies Over-The-Counter Medicines for Sore Throat Product Offered
2.5 Key Companies Time to Begin Mass Production of Over-The-Counter Medicines for Sore Throat
2.6 Over-The-Counter Medicines for Sore Throat 麻豆原创 Competitive Analysis
2.6.1 Over-The-Counter Medicines for Sore Throat 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Over-The-Counter Medicines for Sore Throat Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Over-The-Counter Medicines for Sore Throat as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Lozenges
3.1.2 Syrups
3.1.3 Throat Sprays
3.1.4 Painkillers
3.1.5 Others
3.2 Global Over-The-Counter Medicines for Sore Throat Sales Value by Type
3.2.1 Global Over-The-Counter Medicines for Sore Throat Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Over-The-Counter Medicines for Sore Throat Sales Value, by Type (2019-2030)
3.2.3 Global Over-The-Counter Medicines for Sore Throat Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Online Pharmacy
4.1.2 Offline Pharmacy
4.2 Global Over-The-Counter Medicines for Sore Throat Sales Value by Application
4.2.1 Global Over-The-Counter Medicines for Sore Throat Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Over-The-Counter Medicines for Sore Throat Sales Value, by Application (2019-2030)
4.2.3 Global Over-The-Counter Medicines for Sore Throat Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Over-The-Counter Medicines for Sore Throat Sales Value by Region
5.1.1 Global Over-The-Counter Medicines for Sore Throat Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Over-The-Counter Medicines for Sore Throat Sales Value by Region (2019-2024)
5.1.3 Global Over-The-Counter Medicines for Sore Throat Sales Value by Region (2025-2030)
5.1.4 Global Over-The-Counter Medicines for Sore Throat Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Over-The-Counter Medicines for Sore Throat Sales Value, 2019-2030
5.2.2 North America Over-The-Counter Medicines for Sore Throat Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Over-The-Counter Medicines for Sore Throat Sales Value, 2019-2030
5.3.2 Europe Over-The-Counter Medicines for Sore Throat Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Over-The-Counter Medicines for Sore Throat Sales Value, 2019-2030
5.4.2 Asia Pacific Over-The-Counter Medicines for Sore Throat Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Over-The-Counter Medicines for Sore Throat Sales Value, 2019-2030
5.5.2 South America Over-The-Counter Medicines for Sore Throat Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Over-The-Counter Medicines for Sore Throat Sales Value, 2019-2030
5.6.2 Middle East & Africa Over-The-Counter Medicines for Sore Throat Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Over-The-Counter Medicines for Sore Throat Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Over-The-Counter Medicines for Sore Throat Sales Value
6.3 United States
6.3.1 United States Over-The-Counter Medicines for Sore Throat Sales Value, 2019-2030
6.3.2 United States Over-The-Counter Medicines for Sore Throat Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Over-The-Counter Medicines for Sore Throat Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Over-The-Counter Medicines for Sore Throat Sales Value, 2019-2030
6.4.2 Europe Over-The-Counter Medicines for Sore Throat Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Over-The-Counter Medicines for Sore Throat Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Over-The-Counter Medicines for Sore Throat Sales Value, 2019-2030
6.5.2 China Over-The-Counter Medicines for Sore Throat Sales Value by Type (%), 2023 VS 2030
6.5.3 China Over-The-Counter Medicines for Sore Throat Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Over-The-Counter Medicines for Sore Throat Sales Value, 2019-2030
6.6.2 Japan Over-The-Counter Medicines for Sore Throat Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Over-The-Counter Medicines for Sore Throat Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Over-The-Counter Medicines for Sore Throat Sales Value, 2019-2030
6.7.2 South Korea Over-The-Counter Medicines for Sore Throat Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Over-The-Counter Medicines for Sore Throat Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Over-The-Counter Medicines for Sore Throat Sales Value, 2019-2030
6.8.2 Southeast Asia Over-The-Counter Medicines for Sore Throat Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Over-The-Counter Medicines for Sore Throat Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Over-The-Counter Medicines for Sore Throat Sales Value, 2019-2030
6.9.2 India Over-The-Counter Medicines for Sore Throat Sales Value by Type (%), 2023 VS 2030
6.9.3 India Over-The-Counter Medicines for Sore Throat Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Blackmores Ltd.
7.1.1 Blackmores Ltd. Profile
7.1.2 Blackmores Ltd. Main Business
7.1.3 Blackmores Ltd. Over-The-Counter Medicines for Sore Throat Products, Services and Solutions
7.1.4 Blackmores Ltd. Over-The-Counter Medicines for Sore Throat Revenue (US$ Million) & (2019-2024)
7.1.5 Blackmores Ltd. Recent Developments
7.2 Dr. Willmar Schwabe India Pvt. Ltd.
7.2.1 Dr. Willmar Schwabe India Pvt. Ltd. Profile
7.2.2 Dr. Willmar Schwabe India Pvt. Ltd. Main Business
7.2.3 Dr. Willmar Schwabe India Pvt. Ltd. Over-The-Counter Medicines for Sore Throat Products, Services and Solutions
7.2.4 Dr. Willmar Schwabe India Pvt. Ltd. Over-The-Counter Medicines for Sore Throat Revenue (US$ Million) & (2019-2024)
7.2.5 Dr. Willmar Schwabe India Pvt. Ltd. Recent Developments
7.3 Ernest Jackson & Co. Ltd
7.3.1 Ernest Jackson & Co. Ltd Profile
7.3.2 Ernest Jackson & Co. Ltd Main Business
7.3.3 Ernest Jackson & Co. Ltd Over-The-Counter Medicines for Sore Throat Products, Services and Solutions
7.3.4 Ernest Jackson & Co. Ltd Over-The-Counter Medicines for Sore Throat Revenue (US$ Million) & (2019-2024)
7.3.5 GlaxoSmithKline Plc Recent Developments
7.4 GlaxoSmithKline Plc
7.4.1 GlaxoSmithKline Plc Profile
7.4.2 GlaxoSmithKline Plc Main Business
7.4.3 GlaxoSmithKline Plc Over-The-Counter Medicines for Sore Throat Products, Services and Solutions
7.4.4 GlaxoSmithKline Plc Over-The-Counter Medicines for Sore Throat Revenue (US$ Million) & (2019-2024)
7.4.5 GlaxoSmithKline Plc Recent Developments
7.5 iNova Pharmaceuticals
7.5.1 iNova Pharmaceuticals Profile
7.5.2 iNova Pharmaceuticals Main Business
7.5.3 iNova Pharmaceuticals Over-The-Counter Medicines for Sore Throat Products, Services and Solutions
7.5.4 iNova Pharmaceuticals Over-The-Counter Medicines for Sore Throat Revenue (US$ Million) & (2019-2024)
7.5.5 iNova Pharmaceuticals Recent Developments
7.6 Island Abbey Foods Ltd.
7.6.1 Island Abbey Foods Ltd. Profile
7.6.2 Island Abbey Foods Ltd. Main Business
7.6.3 Island Abbey Foods Ltd. Over-The-Counter Medicines for Sore Throat Products, Services and Solutions
7.6.4 Island Abbey Foods Ltd. Over-The-Counter Medicines for Sore Throat Revenue (US$ Million) & (2019-2024)
7.6.5 Island Abbey Foods Ltd. Recent Developments
7.7 Johnson and Johnson
7.7.1 Johnson and Johnson Profile
7.7.2 Johnson and Johnson Main Business
7.7.3 Johnson and Johnson Over-The-Counter Medicines for Sore Throat Products, Services and Solutions
7.7.4 Johnson and Johnson Over-The-Counter Medicines for Sore Throat Revenue (US$ Million) & (2019-2024)
7.7.5 Johnson and Johnson Recent Developments
7.8 Pfizer Inc.
7.8.1 Pfizer Inc. Profile
7.8.2 Pfizer Inc. Main Business
7.8.3 Pfizer Inc. Over-The-Counter Medicines for Sore Throat Products, Services and Solutions
7.8.4 Pfizer Inc. Over-The-Counter Medicines for Sore Throat Revenue (US$ Million) & (2019-2024)
7.8.5 Pfizer Inc. Recent Developments
7.9 Prestige Consumer Healthcare Inc.
7.9.1 Prestige Consumer Healthcare Inc. Profile
7.9.2 Prestige Consumer Healthcare Inc. Main Business
7.9.3 Prestige Consumer Healthcare Inc. Over-The-Counter Medicines for Sore Throat Products, Services and Solutions
7.9.4 Prestige Consumer Healthcare Inc. Over-The-Counter Medicines for Sore Throat Revenue (US$ Million) & (2019-2024)
7.9.5 Prestige Consumer Healthcare Inc. Recent Developments
7.10 Reckitt Benckiser Group PLC
7.10.1 Reckitt Benckiser Group PLC Profile
7.10.2 Reckitt Benckiser Group PLC Main Business
7.10.3 Reckitt Benckiser Group PLC Over-The-Counter Medicines for Sore Throat Products, Services and Solutions
7.10.4 Reckitt Benckiser Group PLC Over-The-Counter Medicines for Sore Throat Revenue (US$ Million) & (2019-2024)
7.10.5 Reckitt Benckiser Group PLC Recent Developments
7.11 Ricola Ltd.
7.11.1 Ricola Ltd. Profile
7.11.2 Ricola Ltd. Main Business
7.11.3 Ricola Ltd. Over-The-Counter Medicines for Sore Throat Products, Services and Solutions
7.11.4 Ricola Ltd. Over-The-Counter Medicines for Sore Throat Revenue (US$ Million) & (2019-2024)
7.11.5 Ricola Ltd. Recent Developments
7.12 Sanofi SA
7.12.1 Sanofi SA Profile
7.12.2 Sanofi SA Main Business
7.12.3 Sanofi SA Over-The-Counter Medicines for Sore Throat Products, Services and Solutions
7.12.4 Sanofi SA Over-The-Counter Medicines for Sore Throat Revenue (US$ Million) & (2019-2024)
7.12.5 Sanofi SA Recent Developments
7.13 The Procter and Gamble Co.
7.13.1 The Procter and Gamble Co. Profile
7.13.2 The Procter and Gamble Co. Main Business
7.13.3 The Procter and Gamble Co. Over-The-Counter Medicines for Sore Throat Products, Services and Solutions
7.13.4 The Procter and Gamble Co. Over-The-Counter Medicines for Sore Throat Revenue (US$ Million) & (2019-2024)
7.13.5 The Procter and Gamble Co. Recent Developments
7.14 Belmora LLC
7.14.1 Belmora LLC Profile
7.14.2 Belmora LLC Main Business
7.14.3 Belmora LLC Over-The-Counter Medicines for Sore Throat Products, Services and Solutions
7.14.4 Belmora LLC Over-The-Counter Medicines for Sore Throat Revenue (US$ Million) & (2019-2024)
7.14.5 Belmora LLC Recent Developments
7.15 DISCH AG
7.15.1 DISCH AG Profile
7.15.2 DISCH AG Main Business
7.15.3 DISCH AG Over-The-Counter Medicines for Sore Throat Products, Services and Solutions
7.15.4 DISCH AG Over-The-Counter Medicines for Sore Throat Revenue (US$ Million) & (2019-2024)
7.15.5 DISCH AG Recent Developments
7.16 Bliss GVS Pharma Ltd.
7.16.1 Bliss GVS Pharma Ltd. Profile
7.16.2 Bliss GVS Pharma Ltd. Main Business
7.16.3 Bliss GVS Pharma Ltd. Over-The-Counter Medicines for Sore Throat Products, Services and Solutions
7.16.4 Bliss GVS Pharma Ltd. Over-The-Counter Medicines for Sore Throat Revenue (US$ Million) & (2019-2024)
7.16.5 Bliss GVS Pharma Ltd. Recent Developments
7.17 Boyd Pharmaceuticals
7.17.1 Boyd Pharmaceuticals Profile
7.17.2 Boyd Pharmaceuticals Main Business
7.17.3 Boyd Pharmaceuticals Over-The-Counter Medicines for Sore Throat Products, Services and Solutions
7.17.4 Boyd Pharmaceuticals Over-The-Counter Medicines for Sore Throat Revenue (US$ Million) & (2019-2024)
7.17.5 Boyd Pharmaceuticals Recent Developments
7.18 Cipla Health Ltd.
7.18.1 Cipla Health Ltd. Profile
7.18.2 Cipla Health Ltd. Main Business
7.18.3 Cipla Health Ltd. Over-The-Counter Medicines for Sore Throat Products, Services and Solutions
7.18.4 Cipla Health Ltd. Over-The-Counter Medicines for Sore Throat Revenue (US$ Million) & (2019-2024)
7.18.5 Cipla Health Ltd. Recent Developments
7.19 Lozy's Pharmaceuticals
7.19.1 Lozy's Pharmaceuticals Profile
7.19.2 Lozy's Pharmaceuticals Main Business
7.19.3 Lozy's Pharmaceuticals Over-The-Counter Medicines for Sore Throat Products, Services and Solutions
7.19.4 Lozy's Pharmaceuticals Over-The-Counter Medicines for Sore Throat Revenue (US$ Million) & (2019-2024)
7.19.5 Lozy's Pharmaceuticals Recent Developments
7.20 Thornton and Ross Ltd.
7.20.1 Thornton and Ross Ltd. Profile
7.20.2 Thornton and Ross Ltd. Main Business
7.20.3 Thornton and Ross Ltd. Over-The-Counter Medicines for Sore Throat Products, Services and Solutions
7.20.4 Thornton and Ross Ltd. Over-The-Counter Medicines for Sore Throat Revenue (US$ Million) & (2019-2024)
7.20.5 Thornton and Ross Ltd. Recent Developments
7.21 STADA Arzneimittel AG
7.21.1 STADA Arzneimittel AG Profile
7.21.2 STADA Arzneimittel AG Main Business
7.21.3 STADA Arzneimittel AG Over-The-Counter Medicines for Sore Throat Products, Services and Solutions
7.21.4 STADA Arzneimittel AG Over-The-Counter Medicines for Sore Throat Revenue (US$ Million) & (2019-2024)
7.21.5 STADA Arzneimittel AG Recent Developments
8 Industry Chain Analysis
8.1 Over-The-Counter Medicines for Sore Throat Industrial Chain
8.2 Over-The-Counter Medicines for Sore Throat Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Over-The-Counter Medicines for Sore Throat Sales Model
8.5.2 Sales Channel
8.5.3 Over-The-Counter Medicines for Sore Throat Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Blackmores Ltd.
Dr. Willmar Schwabe India Pvt. Ltd.
Ernest Jackson & Co. Ltd
GlaxoSmithKline Plc
iNova Pharmaceuticals
Island Abbey Foods Ltd.
Johnson and Johnson
Pfizer Inc.
Prestige Consumer Healthcare Inc.
Reckitt Benckiser Group PLC
Ricola Ltd.
Sanofi SA
The Procter and Gamble Co.
Belmora LLC
DISCH AG
Bliss GVS Pharma Ltd.
Boyd Pharmaceuticals
Cipla Health Ltd.
Lozy's Pharmaceuticals
Thornton and Ross Ltd.
STADA Arzneimittel AG
听
听
*If Applicable.
